Warning: The NCBI web site requires JavaScript to function. more...
B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin.
Dillon SR, Harder B, Lewis KB, Moore MD, Liu H, Bukowski TR, Hamacher NB, Lantry MM, Maurer M, Krejsa CM, Ellsworth JL, Pederson S, Elkon KB, Wener MH, Dall'Era M, Gross JA.
Arthritis Res Ther. 2010;12(2):R48. Epub 2010 Mar 19.
Related citations
Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts.
Yaccoby S, Pennisi A, Li X, Dillon SR, Zhan F, Barlogie B, Shaughnessy JD Jr.
Leukemia. 2008 Feb;22(2):406-13. Epub 2007 Nov 29.
Systemic lupus erythematosus and its ABCs (APRIL/BLyS complexes).
Stohl W.
Arthritis Res Ther. 2010;12(2):111. Epub 2010 Apr 22.
Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES, Cachero TG, Qian F, Sun Y, Wen D, Pelletier M, Hsu YM, Whitty A.
Biochemistry. 2005 Feb 15;44(6):1919-31.
Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
Morel J, Roubille C, Planelles L, Rocha C, Fernandez L, Lukas C, Hahne M, Combe B.
Ann Rheum Dis. 2009 Jun;68(6):997-1002. Epub 2008 Aug 2.
Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A.
J Immunol. 2004 Mar 1;172(5):3268-79. Erratum in: J Immunol. 2004 Apr 15;172(8):following 5127.
Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
Zhao LD, Li Y, Smith MF Jr, Wang JS, Zhang W, Tang FL, Tian XP, Wang HY, Zhang FC, Ba DN, He W, Zhang X.
Lupus. 2010 Nov;19(13):1534-49.
Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
Kim J, Gross JA, Dillon SR, Min JK, Elkon KB.
Autoimmunity. 2011 Mar;44(2):69-81. Epub 2011 Jan 20.
The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.
Lyu MA, Cheung LH, Hittelman WN, Marks JW, Aguiar RC, Rosenblum MG.
Mol Cancer Ther. 2007 Feb;6(2):460-70. Epub 2007 Jan 31.
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases.
Roschke V, Sosnovtseva S, Ward CD, Hong JS, Smith R, Albert V, Stohl W, Baker KP, Ullrich S, Nardelli B, Hilbert DM, Migone TS.
J Immunol. 2002 Oct 15;169(8):4314-21.
Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI.
Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A.
Curr Biol. 2000 Jun 29;10(13):785-8.
Anticytokine therapy impacting on B cells in autoimmune diseases.
Daridon C, Burmester GR, Dörner T.
Curr Opin Rheumatol. 2009 May;21(3):205-10. Review.
BLyS and APRIL in rheumatoid arthritis.
Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ, Weyand CM.
J Clin Invest. 2005 Nov;115(11):3083-92. Epub 2005 Oct 20.
Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta.
Langat DL, Wheaton DA, Platt JS, Sifers T, Hunt JS.
Am J Pathol. 2008 May;172(5):1303-11. Epub 2008 Apr 10.
Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.
Schneider P, Takatsuka H, Wilson A, Mackay F, Tardivel A, Lens S, Cachero TG, Finke D, Beermann F, Tschopp J.
J Exp Med. 2001 Dec 3;194(11):1691-7.
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
Chiu A, Xu W, He B, Dillon SR, Gross JA, Sievers E, Qiao X, Santini P, Hyjek E, Lee JW, Cesarman E, Chadburn A, Knowles DM, Cerutti A.
Blood. 2007 Jan 15;109(2):729-39. Epub 2006 Sep 7.
The uncertain glory of APRIL.
Medema JP, Planelles-Carazo L, Hardenberg G, Hahne M.
Cell Death Differ. 2003 Oct;10(10):1121-5. Review.
Intrarenal production of B-cell survival factors in human lupus nephritis.
Neusser MA, Lindenmeyer MT, Edenhofer I, Gaiser S, Kretzler M, Regele H, Segerer S, Cohen CD.
Mod Pathol. 2011 Jan;24(1):98-107. Epub 2010 Oct 1.
APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.
Yu G, Boone T, Delaney J, Hawkins N, Kelley M, Ramakrishnan M, McCabe S, Qiu WR, Kornuc M, Xia XZ, Guo J, Stolina M, Boyle WJ, Sarosi I, Hsu H, Senaldi G, Theill LE.
Nat Immunol. 2000 Sep;1(3):252-6.
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.
Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, Clegg CH.
Nature. 2000 Apr 27;404(6781):995-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on